ROSGQ (Rosetta Genomics) Other Current Payables: $0.97 Mil (As of Jun. 2017)


What is Rosetta Genomics Other Current Payables?

Rosetta Genomics ROSGQ -99.00% Other Current Payables is $0.97 Mil as of Jun. 2017.

Rosetta Genomics's Other Current Payables for the quarter that ended in Jun. 2017 was $0.97 Mil.

Rosetta Genomics's quarterly Other Current Payables stayed the same from Jun. 2016 ($0.00 Mil) to Dec. 2016 ($0.00 Mil) but then increased from Dec. 2016 ($0.00 Mil) to Jun. 2017 ($0.97 Mil).

Rosetta Genomics Other Current Payables Related Terms

Rosetta Genomics Other Current Payables Historical Data

* Premium members only.

The historical data trend for Rosetta Genomics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rosetta Genomics Other Current Payables Chart

Rosetta Genomics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Rosetta Genomics Semi-Annual Data
Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.12 0.00 0.00 0.00 0.97

Rosetta Genomics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.97 Mil mean?
Rosetta Genomics (ROSGQ) has a Other Current Payables of $0.97 Mil as of Jun. 2017. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Rosetta Genomics and its competitors.
Is Rosetta Genomics' Other Current Payables too high?
Rosetta Genomics' current Other Current Payables is $0.97 Mil.
How does Rosetta Genomics' Other Current Payables compare to TEAR and IDTA?
Rosetta Genomics' Other Current Payables of $0.97 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Diagnostics & Research company?
A good Other Current Payables depends on the Medical Diagnostics & Research industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Rosetta Genomics and its competitors. Rosetta Genomics's current Other Current Payables is $0.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rosetta Genomics stock overvalued right now?
Rosetta Genomics (ROSGQ) has a current Other Current Payables of $0.97 Mil. The current Other Current Payables is $0.97 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Rosetta Genomics (ROSGQ), the current Other Current Payables is $0.97 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rosetta Genomics Business Description

Address 10 Plaut Street, Science Park, Rehovot, ISR, 76706
Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.